From: Clinicopathological features of HER2 positive metastatic colorectal cancer and survival analysis of anti-HER2 treatment
Variable
HR
95% CI
P
Gender
0.227
0.088 ~ 0.590
0.002
Primary site
3.034
0.810 ~ 11.369
0.100
Metastatic patterns
0.126
0.183 ~ 1.232
Primary lesion resection
4.835
1.491 ~ 15.684
0.009